Library: Deloitte – COVID-19 pandemic shifts insurtech investment priorities
Bolstering virtual customer engagement and operational efficiency
The amount of money invested in insurtechs during the first half of 2020 remained remarkably robust at nearly $2.2 billion, despite the economic fallout and general uncertainty prompted by the COVID-19 outbreak, according to data collected by Venture Scanner and analysed by the Deloitte Center for Financial Services.
Key insurtech insights
- Despite the COVID-19 outbreak and the pandemic’s economic fallout, total insurtech investment through the first half of 2020 appears as robust as it was last year when funds raised reached record levels.
- However, investment was heavily concentrated in a relative handful of insurtechs, while many may struggle to raise additional capital given the ongoing disruption in the economy and shifts in the industry’s needs and priorities.
- The pandemic has prompted many insurers to accentuate their digital transformation efforts and seek insurtechs that can help accelerate virtual interactions in sales and claims, as well as reduce expenses.
- Attention is also expected to shift toward InsurTechs that can provide insurers with more comprehensive, holistic offerings rather than single-point solutions that need to be integrated by the end-user.
InsurTech insights by the numbers
Concerns that the economic fallout of COVID-19 might prompt skittish investors to cut back on InsurTech financing in 2020 may be somewhat alleviated by first-half data collected and reported by Venture Scanner.
Despite a massive rise in unemployment, a flip to negative GDP, and volatile capital markets, insurtech industry investments in the aggregate appear to be as robust as ever. Investment of nearly $2.2 billion recorded by Venture Scanner going to 67 insurtechs during the first half puts the sector well on track to finish with at least the second-highest amount ever, easily topping the $2.7 billion to $3.0 billion full-year figures recorded for 2015, 2017, and 2018 and perhaps even approaching 2019’s record of $5.54 billion (See figure 1.)
It was touch-and-go for a while. First-quarter investments were down slightly—mainly because of a precipitous decline in March, when the COVID-19 outbreak reached the United States, prompting lockdowns, business closings, and a nosedive in the US stock market. This is significant, because 75% of the funds raised in the first half, as recorded by Venture Scanner, were invested in US insurtechs. Yet second-quarter investment was actually higher overall, Venture Scanner data showed, despite dropping more than 50% in April compared with the same month a year earlier. Investment bounced back strongly after that, nearly doubling May 2019’s figure and climbing about 40% year-over-year in June to pull the first half about even with 2019 levels. (See figures 2 and 3.)
A deeper dive into the Venture Scanner data to see where all this money went, however, showed that most of the funding was concentrated among the top 10 InsurTechs, which accounted for nearly two-thirds of all dollars invested in the first half—with the top four dominating by drawing 44% of the total. Such concentration is not new (in the first half of 2019, the top 10 accounted for 53% of all funding), but it is accelerating, a phenomenon becoming more pronounced over the past few years, and described by more than one investor group we interviewed as evidence of an ongoing “flight to quality.” In that context, all remaining insurtechs were left to battle over essentially just one-third of the capital raised in the first half.
See the full report for more…
Link to Full Article:: click here
Link to Source:: click here